Prof. Dr. med. Georg Schett

Lehrstuhl für Innere Medizin III

Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal (2017) O'Neil L, Spicer V, Hitchon CA, Rech J, Hueber A, Wilkins J, El-Gabalawy H, Schett G Conference contribution WNT5A Promotes Tissue Fibrosis By Wnt/PCP-Dependent Activation of Latent TGF-beta (2017) Chen CW, Thuong Trinh-Minh , Lin NY, Zhang Y, Groeber F, Beyer C, Schett G, Distler J Conference contribution TGF-beta-Induced Epigenetic Silencing of SOCS3 Facilitates STAT3 Signaling to Promote Fibroblast Activation and Tissue Fibrosis in Systemic Sclerosis (2017) Dees C, Zhang Y, Pötter S, Bergmann C, Distler O, Schett G, Distler J, Ramming A Conference contribution The Nuclear Receptor ROR-Alpha As a Key Checkpoint of Tissue Repair (2017) Kagwiria R, Liang R, Chen CW, Burris T, Schett G, Distler J Conference contribution MULTI-BIOMARKER DISEASE ACTIVITY AND AUTOANTIBODY STATUS LEAD TO COST EFFECTIVE TAPERING ALGORITHMS IN RHEUMATOID ARTHRITIS PATIENTS IN SUSTAINED REMISSION (2017) Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, et al. Conference contribution ROS is the boss (2017) Hahn J, Kienhofer D, Stoof J, Csepregi JZ, Reinwald C, Maueröder C, Urbonaviciute V, et al. Conference contribution QUANTIFICATION AND IMPACT OF SECONDARY OSTEOARTHRITIS USING HR-PQCT IN ANTI-CITRULLINATED PROTEIN ANTIBODY RHEUMATOID ARTHRITIS PATIENTS (2017) Figueiredo C, Simon D, Englbrecht M, Haschka J, Kleyer A, Bayat S, Hueber A, et al. Conference contribution REGULATION OF ARTHRITIS BY TYPE 2 INNATE LYMPHOID CELLS (2017) Omata Y, Lucas S, Garcia M, Wirtz S, Bozec A, Schett G, Zaiss M Conference contribution Novel mechanism mediated by the IL23/Th17 axis contributing to auto-immune arthritis (2017) Pfeifle R, Rothe T, Ipseiz N, Culemann S, Harre U, Schett G, Krönke G Conference contribution Phase-orientated disease control by cytokines-lessons from rheumatoid arthritis (2017) Schett G Conference contribution